Bennett X-Ray has trailedFischer and Lorad in commercializing a digital spot mammographyproduct, but the Copiague, NY, firm plans to leapfrog the competitionat next week's meeting. Bennett has made strides growing its digitaltechnology thanks to a
Bennett X-Ray has trailedFischer and Lorad in commercializing a digital spot mammographyproduct, but the Copiague, NY, firm plans to leapfrog the competitionat next week's meeting. Bennett has made strides growing its digitaltechnology thanks to a high-tech infusion from the aerospace industry,according to director of sales and marketing Grady Miars.
Bennett received Food and Drug Administration clearance forits M-DSI digital spot mammography system this month (SCAN 11/9/94).M-DSI retrofits to Bennett's Contour and MF-150 mammography devicesand is based on charge-coupled device (CCD) and fiber-optic couplingtechnology.
Bennett has closed the gap with Fischer and Lorad in developinga full-breast digital system, Miars said. Bennett's work-in-progressdevice will not be a scanning-type system but rather will acquirean image of the entire breast in one exposure. Like M-DSI, thesystem is based on CCD technology and will do full-breast digitalexams in the same kV range as traditional mammography exams. Thiswill improve visualization of subtle changes in breast tissue,he said.
Bennett developed the system in cooperation with the Long Islandaerospace firm Northrop Grumman. Earlier this year Bennett acquiredNorthrop Grumman's optical physics department and brought itsengineers to work in-house on mammography-related projects, Miarssaid.
Bennett will also display its work in developing a fiber-opticcommunications network for transmitting digitized mammographyimages to remote sites. The company believes that fiber-optictechnology can transmit data quickly enough to make teleradiologyfor mammography a reality.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
Radiology Experience, Breast Density and Screening Mammography: What New Research Reveals
October 4th 2024In a study looking at the impact of experience and case volume of breast screening radiologists, researchers found that reviewing more than 150 cases per week was necessary to achieve an 80 percent rate of true-positive assessments for malignant calcifications.